A 32-gene risk index： a new prognostic approach for prostate cancer progression

Radical prostatectomy （RP） has been a widely accepted and standard treat-ment for clinically localized and locally advanced prostate cancer. However, effective clinical management of RP patient remains being challenged, given that conventional prognostic factors, including Gleason score, pT stage, s...

Full description

Saved in:
Bibliographic Details
Published in:Asian journal of andrology 2013-09, Vol.15 (5), p.590-591
Main Authors: Cai, Chao, Zhong, Wei-De, McDougal, W Scott, Wu, Chin-Lee
Format: Article
Language:English
Subjects:
Humans
Male
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
PSA
Research Highlight
临床管理
前列腺癌
基因
血清
预后
风险指数
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c393t-3442883015a325c6b4097a9a96d71ea6043ee1df57906014220652835b83fc9e3
container_end_page 591
container_issue 5
container_start_page 590
container_title Asian journal of andrology
container_volume 15
creator Cai, Chao
Zhong, Wei-De
McDougal, W Scott
Wu, Chin-Lee
description Radical prostatectomy （RP） has been a widely accepted and standard treat-ment for clinically localized and locally advanced prostate cancer. However, effective clinical management of RP patient remains being challenged, given that conventional prognostic factors, including Gleason score, pT stage, surgical margin status and presurgery serum prostatespecific antigen （PSA）,
doi_str_mv 10.1038/aja.2013.85
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3881634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>47523236</cqvip_id><sourcerecordid>1429633332</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-3442883015a325c6b4097a9a96d71ea6043ee1df57906014220652835b83fc9e3</originalsourceid><addsrcrecordid>eNpdkd-KEzEUxoMo7h-98l4i3gjL1CRnkkluhGXRVVgQQcG7kKZnpqlt0k2muvsq-yy-k69g2q1Fzc3JOfnx5Us-Qp5xNuEM9Gu3cBPBOEy0fECOedfKphNKPKx7xnSjtPh6RE5KWTAmgBvzmBwJ6FrDGByTT-cURDNgRJpD-UZDnOHNr5931NGIP-g6pyGmMgZP3bo2zs9pn_J2XkY3IvUuetz1Q8ZSQopPyKPeLQs-3ddT8uXd288X75urj5cfLs6vGg8GxgbaVmgNjEsHQno1bZnpnHFGzTqOTrEWEPmsl51hivFWCKak0CCnGnpvEE7Jm3vd9Wa6wpnHOGa3tOscVi7f2uSC_fckhrkd0ncLWnMFbRV4tRfI6XqDZbSrUDwuly5i2hRb7zQK6hIVffkfukibHOvzdpQQxmhZqbN7ytffKRn7gxnO7DYqW6Oy26jsjn7-t_8D-yebCrzYy81THK5DHA5M20lRbSn4DQTdmg4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1429229985</pqid></control><display><type>article</type><title>A 32-gene risk index： a new prognostic approach for prostate cancer progression</title><source>PMC (PubMed Central)</source><creator>Cai, Chao ; Zhong, Wei-De ; McDougal, W Scott ; Wu, Chin-Lee</creator><creatorcontrib>Cai, Chao ; Zhong, Wei-De ; McDougal, W Scott ; Wu, Chin-Lee</creatorcontrib><description>Radical prostatectomy （RP） has been a widely accepted and standard treat-ment for clinically localized and locally advanced prostate cancer. However, effective clinical management of RP patient remains being challenged, given that conventional prognostic factors, including Gleason score, pT stage, surgical margin status and presurgery serum prostatespecific antigen （PSA）,</description><identifier>ISSN: 1008-682X</identifier><identifier>EISSN: 1745-7262</identifier><identifier>DOI: 10.1038/aja.2013.85</identifier><identifier>PMID: 23749003</identifier><language>eng</language><publisher>China: Medknow Publications &amp; Media Pvt. Ltd</publisher><subject>Humans ; Male ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - pathology ; PSA ; Research Highlight ; 临床管理 ; 前列腺癌 ; 基因 ; 血清 ; 预后 ; 风险指数</subject><ispartof>Asian journal of andrology, 2013-09, Vol.15 (5), p.590-591</ispartof><rights>Copyright Nature Publishing Group Sep 2013</rights><rights>Copyright © 2013 SIMM &amp; SJTU 2013 SIMM &amp; SJTU</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c393t-3442883015a325c6b4097a9a96d71ea6043ee1df57906014220652835b83fc9e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84127X/84127X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881634/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881634/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23749003$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cai, Chao</creatorcontrib><creatorcontrib>Zhong, Wei-De</creatorcontrib><creatorcontrib>McDougal, W Scott</creatorcontrib><creatorcontrib>Wu, Chin-Lee</creatorcontrib><title>A 32-gene risk index： a new prognostic approach for prostate cancer progression</title><title>Asian journal of andrology</title><addtitle>Asian Journal of Andrology</addtitle><description>Radical prostatectomy （RP） has been a widely accepted and standard treat-ment for clinically localized and locally advanced prostate cancer. However, effective clinical management of RP patient remains being challenged, given that conventional prognostic factors, including Gleason score, pT stage, surgical margin status and presurgery serum prostatespecific antigen （PSA）,</description><subject>Humans</subject><subject>Male</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - pathology</subject><subject>PSA</subject><subject>Research Highlight</subject><subject>临床管理</subject><subject>前列腺癌</subject><subject>基因</subject><subject>血清</subject><subject>预后</subject><subject>风险指数</subject><issn>1008-682X</issn><issn>1745-7262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpdkd-KEzEUxoMo7h-98l4i3gjL1CRnkkluhGXRVVgQQcG7kKZnpqlt0k2muvsq-yy-k69g2q1Fzc3JOfnx5Us-Qp5xNuEM9Gu3cBPBOEy0fECOedfKphNKPKx7xnSjtPh6RE5KWTAmgBvzmBwJ6FrDGByTT-cURDNgRJpD-UZDnOHNr5931NGIP-g6pyGmMgZP3bo2zs9pn_J2XkY3IvUuetz1Q8ZSQopPyKPeLQs-3ddT8uXd288X75urj5cfLs6vGg8GxgbaVmgNjEsHQno1bZnpnHFGzTqOTrEWEPmsl51hivFWCKak0CCnGnpvEE7Jm3vd9Wa6wpnHOGa3tOscVi7f2uSC_fckhrkd0ncLWnMFbRV4tRfI6XqDZbSrUDwuly5i2hRb7zQK6hIVffkfukibHOvzdpQQxmhZqbN7ytffKRn7gxnO7DYqW6Oy26jsjn7-t_8D-yebCrzYy81THK5DHA5M20lRbSn4DQTdmg4</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Cai, Chao</creator><creator>Zhong, Wei-De</creator><creator>McDougal, W Scott</creator><creator>Wu, Chin-Lee</creator><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Nature Publishing Group</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130901</creationdate><title>A 32-gene risk index： a new prognostic approach for prostate cancer progression</title><author>Cai, Chao ; Zhong, Wei-De ; McDougal, W Scott ; Wu, Chin-Lee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-3442883015a325c6b4097a9a96d71ea6043ee1df57906014220652835b83fc9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Humans</topic><topic>Male</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - pathology</topic><topic>PSA</topic><topic>Research Highlight</topic><topic>临床管理</topic><topic>前列腺癌</topic><topic>基因</topic><topic>血清</topic><topic>预后</topic><topic>风险指数</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cai, Chao</creatorcontrib><creatorcontrib>Zhong, Wei-De</creatorcontrib><creatorcontrib>McDougal, W Scott</creatorcontrib><creatorcontrib>Wu, Chin-Lee</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Health &amp; Medical Complete</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Asian journal of andrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cai, Chao</au><au>Zhong, Wei-De</au><au>McDougal, W Scott</au><au>Wu, Chin-Lee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A 32-gene risk index： a new prognostic approach for prostate cancer progression</atitle><jtitle>Asian journal of andrology</jtitle><addtitle>Asian Journal of Andrology</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>15</volume><issue>5</issue><spage>590</spage><epage>591</epage><pages>590-591</pages><issn>1008-682X</issn><eissn>1745-7262</eissn><abstract>Radical prostatectomy （RP） has been a widely accepted and standard treat-ment for clinically localized and locally advanced prostate cancer. However, effective clinical management of RP patient remains being challenged, given that conventional prognostic factors, including Gleason score, pT stage, surgical margin status and presurgery serum prostatespecific antigen （PSA）,</abstract><cop>China</cop><pub>Medknow Publications &amp; Media Pvt. Ltd</pub><pmid>23749003</pmid><doi>10.1038/aja.2013.85</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1008-682X
ispartof Asian journal of andrology, 2013-09, Vol.15 (5), p.590-591
issn 1008-682X
1745-7262
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3881634
source PMC (PubMed Central)
subjects Humans
Male
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
PSA
Research Highlight
临床管理
前列腺癌
基因
血清
预后
风险指数
title A 32-gene risk index： a new prognostic approach for prostate cancer progression
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T00%3A36%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%2032-gene%20risk%20index%EF%BC%9A%20a%20new%20prognostic%20approach%20for%20prostate%20cancer%20progression&rft.jtitle=Asian%20journal%20of%20andrology&rft.au=Cai,%20Chao&rft.date=2013-09-01&rft.volume=15&rft.issue=5&rft.spage=590&rft.epage=591&rft.pages=590-591&rft.issn=1008-682X&rft.eissn=1745-7262&rft_id=info:doi/10.1038/aja.2013.85&rft_dat=%3Cproquest_pubme%3E1429633332%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c393t-3442883015a325c6b4097a9a96d71ea6043ee1df57906014220652835b83fc9e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1429229985&rft_id=info:pmid/23749003&rft_cqvip_id=47523236&rfr_iscdi=true